See How CAR T-Cell Therapy is Changing the Way Cancer is Treated
Explore insights from BioAgilytix’s Dr. Afshin Safavi on some of the innovations taking place in the immuno-oncology field, particularly with CAR T therapies, in one of his latest blog posts.
Read More